[144] Protagonist Therapeutics, Inc SEC Filing
PTGX filed a Form 144 notice for a planned sale of 18,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PTGX filed a Form 144 notice for a planned sale of 18,000 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $1,483,495.20 and 62,515,666 shares outstanding. The securities were acquired on February 17, 2026 through a stock option exercise paid in cash on the same date.
AI-generated analysis. How Rhea-AI works. Not financial advice.